Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v1-EN
Language English English
Date Updated 2017-10-23 2017-07-26
Drug Identification Number 02213222 02213222
Brand name ELTROXIN ELTROXIN
Common or Proper name levothyroxine sodium levothyroxine sodium
Company Name ASPEN PHARMACARE CANADA INC. ASPEN PHARMACARE CANADA INC.
Ingredients LEVOTHYROXINE SODIUM LEVOTHYROXINE SODIUM
Strength(s) 200MCG 200MCG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 500 tablets 500 tablets
ATC code H03AA H03AA
ATC description THYROID PREPARATIONS THYROID PREPARATIONS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2017-07-26 2017-07-26
Estimated end date 2017-10-17 2017-09-25
Actual end date 2017-10-23
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments We will confirm shortly when next supply date is available.
Health Canada comments